Furthermore, we showed that in vitro Geminin poly-ubiquitination by SPOP was abolished in the context of SPOP F102C and F133V, two SPOP mutations most frequently found in prostate cancer patient specimens (Fig. 3f). Here, GMNN is linked to prostate carcinoma.